Fractyl
Brian Dovey has been a partner of Domain since 1988, where he has led innovative investments in life sciences companies. Since joining Domain, he has served on the boards of directors of more than 35 private and public companies and has been chairman of six.
Prior to Domain, Brian was president of Rorer Group, now a part of Sanofi, where he was the primary architect of a strategy transforming the company from a diversified medical products company to a fully integrated pharmaceutical company, doubling sales with a multi-fold increase in profits.
Previous to that, Brian was president of Survival Technology, a start-up medical products company whose sales growth placed it in the top ten of the Inc 100. Brian was formerly chairman and currently serves on the boards of directors of both the Center for Venture Education (Kauffman Fellows Program) and the Wistar Institute, a leader in preclinical bio-medical research in the non-profit sector. He received his B.A. in mathematics from Colgate University and his MBA from Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Fractyl
2 followers
Fractyl aims to bring curative therapies to the large populations of patients with metabolic disease. With their innovative products, their goal is to truly shift the treatment paradigm for patients with metabolic disease by focusing on their root cause in the intestine to provide meaningful, transformative, benefits to restore patient health from metabolic diseases.